Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
The Accelerator will develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).
Bayer now present in four of the largest biotechnology hubs in the United States
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
The £118 million Mazumdar-Shaw Advanced Research Centre (ARC) will be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.
A big boost to healthcare efforts of Ayush through NARIP, CCRAS
TP-3654 is currently being evaluated in a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with intermediate or high-risk primary or secondary myelofibrosis.
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
Subscribe To Our Newsletter & Stay Updated